Processa Pharmaceuticals, Inc. General form of registration statement for all companies including face-amount certificate companies

Operating Leases (Tables)

9 Months Ended

Sep. 30, 2019

The weighted average remaining lease terms and discount rate for our operating leases were as follows at September 30, 2019:

Weighted average remaining lease term (years) for our facility and equipment leases			2.6
Weighted average discount rate for our facility and equipment leases			8	%

Maturities of our lease liabilities for all operating leases were as follows as of September 30, 2019:

2019	$	23,396
2020		92,603
2021		90,495
2022		69,741
Total lease payments		276,235
Less: Interest		(32,073	)
Present value of lease liabilities		244,162
Less: current maturities		(77,423	)
Non-current lease liability	$	166,739